Lane Labs BeneFin Is Unapproved Drug - FDA Complaint

20 Dec 1999

• By The Tan Sheet

FDA is seeking a permanent injunction against the sale of Lane Labs-USA's BeneFin, SkinAnswer and MGN-3 products, alleging they are "unapproved drugs" and "illegally promoted as treatments for cancer and other diseases."

Lane Labs BeneFin Is Unapproved Drug - FDA Complaint

More from Archive

More from Pink Sheet